{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:23:34Z","timestamp":1787847814098,"version":"build-2784847793"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study evaluated the effectiveness of stool DNA methylation markers Cannabinoid Receptor Type 1 (CNRIP1), Secreted Frizzled-Related Protein 2 (SFRP2), and Vimentin (VIM), along with Fecal Occult Blood Testing (FOBT), in the non-invasive screening for colorectal cancer (CRC), further integrating these markers with the Light Gradient Boosting Machine (LightGBM) machine learning (ML) algorithm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The study analyzed 100 stool samples (50 CRC, 50 normal) to assess the methylation status of CNRIP1, SFRP2, and VIM gene promoters. FOBT was performed in parallel. Diagnostic performance was assessed using Receiver Operating Characteristic (ROC) curve analysis, and a LightGBM-based ML model was developed, incorporating methylation markers and FOBT results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>ROC analysis demonstrated that SFRP2 had the highest diagnostic accuracy with an area under the curve (AUC) of 0.87 (95% confidence interval [CI]: 0.794\u20130.946) and a sensitivity of 0.88. CNRIP1 and VIM also showed substantial screening effectiveness, with AUC values of 0.83 and 0.80, respectively. FOBT, in comparison, had a lower predictive value with an AUC of 0.67. The LightGBM-based ML model significantly outperformed individual markers, achieving a high AUC of 0.95 (95% CI: 0.916\u20130.991). However, the sensitivity of the ML model was 0.78, suggesting a need for improvement in correctly identifying all CRC cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Stool DNA methylation markers CNRIP1, SFRP2, and VIM exhibited high sensitivity in non-invasive CRC screening. The integration of these biomarkers with the LightGBM ML algorithm enhanced diagnostic accuracy, offering a promising approach for early CRC detection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_436_24","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:00:38Z","timestamp":1779951638000},"page":"432-440","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing non-invasive colorectal cancer screening with stool DNA methylation markers and light gradient-boosting machine learning"],"prefix":"10.4103","volume":"22","author":[{"given":"Gangfeng","family":"Zhu","sequence":"first","affiliation":[{"name":"First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Zhu","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenghong","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, Jiangxi Province, China"},{"name":"Jiangxi Clinical Research Center for Cancer, Gannan Medical University, Ganzhou, Jiangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangjian","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, Jiangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, Jiangxi Province, China"},{"name":"Jiangxi Clinical Research Center for Cancer, Gannan Medical University, Ganzhou, Jiangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, Jiangxi Province, China"},{"name":"Jiangxi Clinical Research Center for Cancer, Gannan Medical University, Ganzhou, Jiangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangcai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, Jiangxi Province, China"},{"name":"Jiangxi Clinical Research Center for Cancer, Gannan Medical University, Ganzhou, Jiangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueming","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, Jiangxi Province, China"},{"name":"Jiangxi Clinical Research Center for Cancer, Gannan Medical University, Ganzhou, Jiangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, Jiangxi Province, China"},{"name":"Jiangxi Clinical Research Center for Cancer, Gannan Medical University, Ganzhou, Jiangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"R1-20260528","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: A systematic analysis for the global burden of disease study 2019","volume":"8","author":"Kocarnik","year":"2022","journal-title":"JAMA Oncol"},{"key":"R2-20260528","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4103\/jcrt.jcrt_2367_22","article-title":"Epidemiological trends of colorectal cancer cases in young population of Eastern India: A retrospective observational study","volume":"20","author":"Raj","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"R3-20260528","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(14)70029-4","article-title":"Challenges to effective cancer control in China, India, and Russia","volume":"15","author":"Goss","year":"2014","journal-title":"Lancet Oncol"},{"key":"R4-20260528","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: Incidence and mortality estimates from GLOBOCAN","volume":"72","author":"Morgan","year":"2023","journal-title":"Gut"},{"key":"R5-20260528","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.2147\/OTT.S122425","article-title":"Diagnosis reliability of combined flexible sigmoidoscopy and fecal-immunochemical test in colorectal neoplasia screening","volume":"9","author":"Iovanescu","year":"2016","journal-title":"Onco Targets Ther"},{"key":"R6-20260528","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/gutjnl-2015-309800","article-title":"Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer","volume":"66","author":"Yu","year":"2017","journal-title":"Gut"},{"key":"R7-20260528","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mam.2019.06.002","article-title":"Circulating biomarkers for early detection and clinical management of colorectal cancer","volume":"69","author":"Marcuello","year":"2019","journal-title":"Mol Aspects Med"},{"key":"R8-20260528","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1038\/s41598-021-81900-6","article-title":"Detection of colorectal cancer in urine using DNA methylation analysis","volume":"11","author":"Bach","year":"2021","journal-title":"Sci Rep"},{"key":"R9-20260528","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1136\/gutjnl-2019-318532","article-title":"A novel faecal Lachnoclostridium marker for the non-invasive diagnosis of colorectal adenoma and cancer","volume":"69","author":"Liang","year":"2020","journal-title":"Gut"},{"key":"R10-20260528","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.4103\/jcrt.jcrt_2188_21","article-title":"Promoter methylation of matrix metallopeptidase 9 in peripheral blood mononuclear cells: A novel biomarker in a promising source for noninvasive colorectal cancer diagnosis","volume":"19","author":"Shaygannejad","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"R11-20260528","doi-asserted-by":"crossref","first-page":"e00375","DOI":"10.14309\/ctg.0000000000000375","article-title":"Detection of postcolonoscopy colorectal neoplasia by multi-target stool DNA","volume":"12","author":"Ebner","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"issue":"Suppl","key":"R12-20260528","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4103\/0973-1482.151534","article-title":"The diagnostic value of DNA hypermethylation in stool for colorectal cancer: A meta-analysis","volume":"10","author":"Qian","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"R13-20260528","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/00031348211031844","article-title":"Retrospective review of multitarget stool DNA as a screening test for colorectal cancer","volume":"89","author":"Kleinschmidt","year":"2023","journal-title":"Am Surg"},{"key":"R14-20260528","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12029-024-01118-3","article-title":"The utility of multitarget stool DNA testing for colorectal cancer screening after a normal colonoscopy","volume":"56","author":"Rao","year":"2024","journal-title":"J Gastrointest Cancer"},{"key":"R15-20260528","doi-asserted-by":"crossref","first-page":"188722","DOI":"10.1016\/j.bbcan.2022.188722","article-title":"DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer","volume":"1877","author":"M\u00fcller","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R16-20260528","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.3390\/molecules24203672","article-title":"Cannabinoid receptor interacting protein 1a (CRIP1a): Function and structure","volume":"24","author":"Booth","year":"2019","journal-title":"Molecules"},{"key":"R17-20260528","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1476-4598-10-85","article-title":"Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas","volume":"10","author":"Lind","year":"2011","journal-title":"Mol Cancer"},{"key":"R18-20260528","doi-asserted-by":"crossref","first-page":"33339","DOI":"10.1038\/srep33339","article-title":"Methylation of SFRP2 gene as a promising noninvasive biomarker using feces in colorectal cancer diagnosis: A systematic meta-analysis","volume":"6","author":"Yang","year":"2016","journal-title":"Sci Rep"},{"key":"R19-20260528","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cca.2014.01.044","article-title":"Validation of methylation-sensitive high-resolution melting (MS-HRM) for the detection of stool DNA methylation in colorectal neoplasms","volume":"431","author":"Xiao","year":"2014","journal-title":"Clin Chim Acta"},{"key":"R20-20260528","first-page":"1009","article-title":"The association of vimentin and fibronectin gene expression with epithelial-mesenchymal transition and tumor malignancy in colorectal carcinoma","volume":"16","author":"Niknami","year":"2017","journal-title":"EXCLI J"},{"key":"R21-20260528","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/path.6155","article-title":"Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer","volume":"260","author":"Thagaard","year":"2023","journal-title":"J Pathol"},{"key":"R22-20260528","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1038\/s41467-022-30841-3","article-title":"Automated detection and segmentation of non-small cell lung cancer computed tomography images","volume":"13","author":"Primakov","year":"2022","journal-title":"Nat Commun"},{"key":"R23-20260528","doi-asserted-by":"crossref","first-page":"100086","DOI":"10.1016\/j.engmed.2025.100086","article-title":"Advancements and future directions of artificial intelligence in tumor imaging: A comprehensive review of techniques and applications","volume":"2","author":"Xue","year":"2025","journal-title":"EngMedicine"},{"key":"R24-20260528","doi-asserted-by":"crossref","first-page":"100024","DOI":"10.1016\/j.engmed.2024.100024","article-title":"Research progress of artificial intelligence in evaluating the efficacy of neoadjuvant chemotherapy for breast cancer","volume":"1","author":"Wei","year":"2024","journal-title":"EngMedicine"},{"key":"R25-20260528","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41551-021-00746-5","article-title":"Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning","volume":"5","author":"Liang","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"R26-20260528","doi-asserted-by":"crossref","first-page":"1072273","DOI":"10.3389\/fphys.2023.1072273","article-title":"Blood pressure stratification using photoplethysmography and light gradient boosting machine","volume":"14","author":"Hu","year":"2023","journal-title":"Front Physiol"},{"key":"R27-20260528","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3390\/diagnostics11091714","article-title":"Diagnosis of diabetes mellitus using gradient boosting machine (LightGBM)","volume":"11","author":"Rufo","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"R28-20260528","doi-asserted-by":"crossref","first-page":"9517029","DOI":"10.1155\/2022\/9517029","article-title":"Length of stay prediction model of indoor patients based on light gradient boosting machine","volume":"2022","author":"Zeng","year":"2022","journal-title":"Comput Intell Neurosci"},{"key":"R29-20260528","doi-asserted-by":"crossref","first-page":"giaa071","DOI":"10.1093\/gigascience\/giaa071","article-title":"Assessment of fecal DNA extraction protocols for metagenomic studies","volume":"9","author":"Yang","year":"2020","journal-title":"Gigascience"},{"key":"R30-20260528","doi-asserted-by":"crossref","first-page":"15889","DOI":"10.1038\/s41598-022-20149-z","article-title":"Gradient boosting decision tree becomes more reliable than logistic regression in predicting probability for diabetes with big data","volume":"12","author":"Seto","year":"2022","journal-title":"Sci Rep"},{"key":"R31-20260528","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev-med-103018-123125","article-title":"Fecal DNA testing for colorectal cancer screening","volume":"71","author":"Carethers","year":"2020","journal-title":"Annu Rev Med"},{"key":"R32-20260528","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.mayocp.2020.07.035","article-title":"Cost-effectiveness of multitarget stool DNA testing vs colonoscopy or fecal immunochemical testing for colorectal cancer screening in Alaska Native People","volume":"96","author":"Redwood","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"R33-20260528","doi-asserted-by":"crossref","first-page":"7567","DOI":"10.1038\/s41598-021-87171-5","article-title":"Development of machine learning model for diagnostic disease prediction based on laboratory tests","volume":"11","author":"Park","year":"2021","journal-title":"Sci Rep"},{"key":"R34-20260528","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12539-021-00488-7","article-title":"DeepStack-DTIs: Predicting drug-target interactions using LightGBM feature selection and deep-stacked ensemble classifier","volume":"14","author":"Zhang","year":"2022","journal-title":"Interdiscip Sci"},{"key":"R35-20260528","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1038\/s41598-021-84504-2","article-title":"Machine learning-based prediction model using clinico-pathologic factors for papillary thyroid carcinoma recurrence","volume":"11","author":"Park","year":"2021","journal-title":"Sci Rep"},{"key":"R36-20260528","doi-asserted-by":"crossref","first-page":"5297235","DOI":"10.1155\/2022\/5297235","article-title":"Identification of methylation signatures and rules for sarcoma subtypes by machine learning methods","volume":"2022","author":"Ren","year":"2022","journal-title":"Biomed Res Int"},{"key":"R37-20260528","doi-asserted-by":"crossref","first-page":"e23400","DOI":"10.1002\/bip.23400","article-title":"Understanding mass spectrometry images: Complexity to clarity with machine learning","volume":"112","author":"Gardner","year":"2021","journal-title":"Biopolymers"},{"key":"R38-20260528","doi-asserted-by":"crossref","first-page":"e1010328","DOI":"10.1371\/journal.pcbi.1010328","article-title":"Explainable deep transfer learning model for disease risk prediction using high-dimensional genomic data","volume":"18","author":"Liu","year":"2022","journal-title":"PLoS Comput Biol"},{"key":"R39-20260528","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1148\/radiol.2021202363","article-title":"Machine learning-based differentiation of benign and premalignant colorectal polyps detected with CT colonography in an asymptomatic screening population: A proof-of-concept study","volume":"299","author":"Grosu","year":"2021","journal-title":"Radiology"},{"key":"R40-20260528","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1177\/0272989X231184175","article-title":"Calibration and validation of the colorectal cancer and adenoma incidence and mortality (CRC-AIM) microsimulation model using deep neural networks","volume":"43","author":"Vahdat","year":"2023","journal-title":"Med Decis Making"},{"key":"R41-20260528","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejca.2023.01.011","article-title":"A machine learning tool for identifying non-metastatic colorectal cancer in primary care","volume":"182","author":"Nemlander","year":"2023","journal-title":"Eur J Cancer"},{"key":"R42-20260528","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1001\/jama.2014.15746","volume":"312","year":"2014","journal-title":"JAMA"},{"key":"R43-20260528","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-023-01866-z","article-title":"Efficacy of cell-free DNA methylation-based blood test for colorectal cancer screening in high-risk population: A prospective cohort study","volume":"22","author":"Zhao","year":"2023","journal-title":"Mol Cancer"},{"key":"R44-20260528","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1148\/radiol.2020201018","article-title":"Diagnostic performance of multitarget stool DNA and CT colonography for noninvasive colorectal cancer screening","volume":"297","author":"Pickhardt","year":"2020","journal-title":"Radiology"},{"key":"R45-20260528","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00464-012-2543-6","article-title":"Colorectal cancer following negative colonoscopy: Is 5-year screening the correct interval to recommend?","volume":"27","author":"Nakao","year":"2013","journal-title":"Surg Endosc"},{"key":"R46-20260528","doi-asserted-by":"crossref","first-page":"1256876","DOI":"10.3389\/fped.2023.1256876","article-title":"DNA methylation-based diagnosis confirmation in a pediatric patient with low-grade glioma: A case report","volume":"11","author":"Morgacheva","year":"2023","journal-title":"Front Pediatr"},{"key":"R47-20260528","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S2352-4642(19)30342-6","article-title":"DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: A population-based study","volume":"4","author":"Pickles","year":"2020","journal-title":"Lancet Child Adolesc Health"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_436_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:39:22Z","timestamp":1787845162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_436_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_436_24","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2024-02-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}